Overview

Administration During Chemotherapy to Reduce Ovarian Failure Following Chemotherapy in Early Stage, Hormone-Receptor Negative Breast Cancer

Status:
Completed

Trial end date:
2012-11-01

Target enrollment:

Participant gender:

Summary

This is a phase III trial of LHRH analog administration during chemotherapy to reduce ovarian failure following chemotherapy in early stage, hormone-receptor negative breast cancer.

Phase:

Phase 3

Details

Lead Sponsor:

King Faisal Specialist Hospital & Research Center

Treatments:

Cyclophosphamide
Goserelin
Hormones
Polystyrene sulfonic acid